A Study of Radiotherapy Planning System Software ---- Zeus Cloud

Status Not yet recruiting

Clinical Trial Summary

To evaluate the feasibility of Zeus Cloud TPS in the design of photon intensity modulated radiation therapy (IMRT) plan for tumors in various parts of the body.

Clinical Trial Description

This is a self-control, multi-center non-inferiority study. Subjects meeting inclusion criteria have radiation treatment plans designed by Zeus Cloud TPS and Eclipse treatment planning software from Varian, respectively. The qualities of two plans are compared.

This is a observational study as the two plans are not executed. ;

Study Design

Related Conditions & MeSH terms

Radiotherapy

Clinical Trial Details

NCT number	NCT04579718
Study type	Observational
Source	Sun Yat-sen University
Contact	Bo Qiu, MD
Phone	+86-020-87343031
Email	qiubo@sysucc.org.cn
Status	Not yet recruiting
Phase
Start date	November 1, 2020
Completion date	October 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03212742` - Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients	Phase 1/Phase 2
Recruiting	`NCT06190782` - Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor	Phase 3
Recruiting	`NCT06120127` - Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence	Phase 2
Recruiting	`NCT05176002` - Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.	Phase 1/Phase 2
Not yet recruiting	`NCT05909137` - Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer
Recruiting	`NCT02661152` - DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC.	Phase 3
Withdrawn	`NCT02542137` - Abscopal Effect for Metastatic Small Cell Lung Cancer	Phase 2
Completed	`NCT01212731` - Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study
Completed	`NCT01168479` - FLAME: Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate Cancer	Phase 3
Recruiting	`NCT03658343` - T2* MRI Analysis for Sarcoma	N/A
Completed	`NCT03280719` - Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 Fractions	N/A
Recruiting	`NCT05514327` - A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL	N/A
Recruiting	`NCT05515796` - Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors	Phase 2
Recruiting	`NCT04453826` - Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma	Phase 3
Recruiting	`NCT03370926` - FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy	N/A
Active, not recruiting	`NCT03870919` - Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients	N/A
Active, not recruiting	`NCT02428049` - Radiation Pneumonitis After SBRT for NSCLC
Recruiting	`NCT04923620` - Neoadjuvant Cetuximab + Chemotherapy Combined With Short-course Radiotherapy
Active, not recruiting	`NCT05371795` - Comparison on Radiotherapy Permanent Skin Marking With Lancets and an Electric Marking Device	N/A
Recruiting	`NCT03210428` - Quantitative MR Imaging in Locally Advanced Cervical Cancer